Ocular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degeneration.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  American journal of ophthalmology-glaucoma

• Publication date

  2011-04-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ajo.2011.01.053PMID 21664593PMCID PMC3143287
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intravitreal bevacizumab and ranibizumab for age-related macular degeneration a multicenter, retrospective study.

  2010cited by this paper
• Severe intraocular inflammation after intravitreal injection of bevacizumab.

  2010cited by this paper
• Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials.

  2009cited by this paper
• Antiangiogenic approaches to age-related macular degeneration today.

  2009cited by this paper
• Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.

  2009cited by this paper
• INFECTIOUS ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTIANGIOGENIC AGENTS

  2009cited by this paper
• EVALUATION OF SAFETY FOR BILATERAL SAME-DAY INTRAVITREAL INJECTIONS OF ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY

  2009cited by this paper
• SAFETY OF REPEAT INTRAVITREAL INJECTIONS OF BEVACIZUMAB VERSUS RANIBIZUMAB: Our Experience After 2,000 Injections

  2009cited by this paper
• INCIDENCE OF ENDOPHTHALMITIS RELATED TO INTRAVITREAL INJECTION OF BEVACIZUMAB AND RANIBIZUMAB

  2008cited by this paper
• Twelve-month safety of intravitreal injections of bevacizumab (Avastin®): results of the Pan-American Collaborative Retina Study Group (PACORES)

  2007cited by this paper
• A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study

  2007cited by this paper
• Ranibizumab for neovascular age-related macular degeneration.

  2006cited by this paper
• External Validation of Medicare Claims for Breast Cancer Chemotherapy Compared With Medical Chart Reviews

  2006cited by this paper
• Pegaptanib for neovascular age-related macular degeneration.

  2004cited by this paper
• Age-related macular degeneration causing visual impairment in people 75 years or older in Britain: an add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community.

  2004cited by this paper
• RISKS OF INTRAVITREOUS INJECTION: A COMPREHENSIVE REVIEW

  2004cited by this paper
• Global data on visual impairment in the year 2002.

  2004cited by this paper
• Prevalence of age-related macular degeneration in the United States.

  2004cited by this paper
• Use of SEER-Medicare Data for Measuring Cancer Surgery

  2002cited by this paper
• Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores.

  2001cited by this paper
• Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

  1998cited by this paper
• Accuracy of coding in Medicare part B claims. Cataract as a case study.

  1993cited by this paper
• A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

  1987cited by this paper
• The central role of the propensity score in observational studies for causal effects

  1983cited by this paper

• The Effect of Intravitreal Ranibizumab Injection on Retinal Nerve Fiber Layer Thickness and Optic Disc Parameters

  2026cites this paper
• Real-world experience of intravitreal faricimab injection in previously treated neovascular age-related macular degeneration eyes: a case series

  2025influential citation
• Ref‐1 redox activity regulates retinal neovascularization by modulating transcriptional activation of HIF‐1α

  2025cites this paper
• Functional scaffolds design strategies for retinal repair and regeneration

  2025cites this paper
• Pharmacokinetic model for drug delivery by Ozurdex

  2025cites this paper
• Ultrasound Biomicroscopy of Patients With Hemorrhagic Complications Following Intravitreal Antivascular Endothelial Growth Factor Injection

  2025cites this paper
• Efficacy of Intravitreal Injection of Etamsylate in Inflammation and Angiogenesis-dependent Ocular Diseases

  2025cites this paper
• Chlorhexidine Compared with Povidone–Iodine in Intravitreal Injection: A Systematic Review and Meta-Analysis

  2025cites this paper
• Progress in Aptamer Research and Future Applications.

  2025cites this paper
• Variations in Using Diagnosis Codes for Defining Age-Related Macular Degeneration Cohorts

  2024cites this paper
• Exploring the Spectrum of VEGF Inhibitors’ Toxicities from Systemic to Intra-Vitreal Usage in Medical Practice

  2024cites this paper
• Diabetic Retinopathy (DR)

  2024cites this paper
• Photobiomodulation for diabetes and its complications: a review of general presentation, mechanisms and efficacy

  2024cites this paper
• Towards Motion Compensation in Autonomous Robotic Subretinal Injections

  2024cites this paper
• Investigation of novel combination therapy for age-related macular degeneration on ARPE-19 cells

  2024cites this paper
• Beyond VEGF: Targeting Inflammation and Other Pathways for Treatment of Retinal Disease

  2023cites this paper
• Lentiviral delivered aflibercept OXB-203 for treatment of neovascular AMD

  2023cites this paper
• Ocular point-of-care ultrasound in the detection of early endophthalmitis

  2023influential citation
• Recombinant Spider Silk Bioinks for Continuous Protein Release by Encapsulated Producer Cells.

  2022cites this paper
• Acquired Methemoglobinemia in a Ketamine-induced Ulcerative Cystitis Patient: A Case Report

  2022cites this paper
• Post-intravitreal Injection Endophthalmitis Identified with Point-of-care Ultrasound

  2022cites this paper
• Prediction of treatment outcome in neovascular age-related macular degeneration using a novel convolutional neural network

  2022cites this paper
• A randomized, double-masked, multicenter trial of topical acrizanib (LHA510), a tyrosine kinase VEGF-receptor inhibitor, in treatment-experienced subjects with neovascular age-related macular degeneration.

  2022cites this paper
• Novel Therapeutics for Diabetic Retinopathy and Diabetic Macular Edema: A Pathophysiologic Perspective

  2022cites this paper
• Immune-related adverse events of cancer immunotherapies targeting kinases.

  2022cites this paper
• APE1/Ref-1 as a Novel Target for Retinal Diseases

  2021cites this paper
• Postprocedural Endophthalmitis or Postprocedural Intraocular Inflammation: A Diagnostic Conundrum

  2021cites this paper
• Unusual endophthalmitis with macular infarction

  2021cites this paper
• Pharmacologically-induced uveitis.

  2021cites this paper
• Medication-induced Uveitis: An Update

  2021cites this paper
• [Drug-induced uveitis].

  2021cites this paper
• Case Report: Acute Retinal Necrosis after Intravitreal Ranibizumab for Exudative Macular Degeneration

  2021cites this paper
• Characteristics and surgical outcomes of rhegmatogenous retinal detachments that develop after intravitreal injections

  2021cites this paper
• [Ophthalmic safety profile of antiangiogenic therapy].

  2021cites this paper
• Blocking the interaction between interleukin-17A and endoplasmic reticulum stress in macrophage attenuates retinal neovascularization in oxygen-induced retinopathy

  2021cites this paper
• DABCO-Customized Nanoemulsions: Characterization, Cell Viability and Genotoxicity in Retinal Pigmented Epithelium and Microglia Cells

  2021cites this paper
• Inhibition of APE1/Ref-1 for Neovascular Eye Diseases: From Biology to Therapy

  2021cites this paper
• The IL‐23/IL‐17 axis promotes the formation of retinal neovascularization by activating the NLRP3 inflammasome in macrophages in an experimental retinopathy mouse model

  2021cites this paper
• Rates of Suspected Endophthalmitis Following Intravitreal Injections in Clinical Practices in the United States.

  2021cites this paper
• Long-term stability of anti-vascular endothelial cell growth factor (a-VGEF) biologics under physiologically relevant conditions and its impact on the development of long-acting delivery systems.

  2020cites this paper
• Literature Review

  2020cites this paper
• Factors Affecting Compliance to Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in a Cohort of Jordanian Patients

  2020cites this paper
• Inhibition of laser induced rats choroidal neovascularization by intravitreous injection of sEphB4-HSA

  2020cites this paper
• Inhibiting the NLRP3 inflammasome with MCC950 ameliorates retinal neovascularization and leakage by reversing the IL-1β/IL-18 activation pattern in an oxygen-induced ischemic retinopathy mouse model

  2020cites this paper
• Reporting of Safety Events during Anti-VEGF Treatment: Pharmacovigilance in a Noninterventional Trial

  2020cites this paper
• Toward Drug-Like Multispecific Antibodies by Design

  2020cites this paper
• Microsphere antioxidant and sustained erythropoietin-R76E release functions cooperate to reduce traumatic optic neuropathy.

  2020cites this paper
• Klebsiella Cluster Endophthalmitis following Intravitreal Bevacizumab: Role of Early Detection, Pars Plana Vitrectomy, and Intracameral Moxifloxacin

  2020cites this paper
• Modulation of immune cell reactivity with cis-binding Siglec agonists

  2020cites this paper
• Molecular Mechanisms of Retina Pathology and Ways of its Correction

  2020cites this paper
• Effect of Repeated Intravitreal Ranibizumab and Aflibercept Injections on the Cornea in Patients with Age-Related Macular Degeneration

  2020cites this paper
• Novel Cell-Based and Tissue Engineering Approaches for Induction of Angiogenesis as an Alternative Therapy for Diabetic Retinopathy

  2020cites this paper
• Factors Affecting Compliance to Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in a Cohort of Jordanian Patients

  2020cites this paper
• Survey of Intravitreal Injection Practice Patterns Among Retina Specialists

  2020cites this paper
• Incidence of endophthalmitis after intravitreal injection with and without topical antibiotic prophylaxis

  2020cites this paper
• The Short-Term Efficacy of Biweekly Subconjunctival Bevacizumab in Diabetic Macular Edema

  2020cites this paper
• Molecular-Physiological Aspects of Regulatory Effect of Peptide Retinoprotectors

  2019cites this paper
• Repositioning of Itraconazole for the Management of Ocular Neovascularization Through Surface-Modified Nanostructured Lipid Carriers

  2019cites this paper
• An in vitro Assessment of Thermo-Reversible Gel Formulation Containing Sunitinib Nanoparticles for Neovascular Age-Related Macular Degeneration

  2019cites this paper
• Diabetic Retinopathy in Youth-Onset Type 2 Diabetes Mellitus

  2019cites this paper
• Extended release of dexamethasone from oleogel based rods.

  2019cites this paper
• Long-term changes in retinal layers in patients undergoing intravitreal ranibizumab for neovascular age-related macular degeneration

  2019cites this paper
• LONG-TERM VISUAL OUTCOMES AND CLINICAL FEATURES AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTION-RELATED ENDOPHTHALMITIS.

  2019cites this paper
• Prefilled syringes for intravitreal drug delivery

  2019cites this paper
• Vitreous hemorrhage as an early sign of acute bacterial endophthalmitis following intravitreal ranibizumab injection

  2018cites this paper
• New Therapies of Neovascular AMD—Beyond Anti-VEGFs

  2018cites this paper
• Overview and Current Recommendations for the Treatment of Bacterial Endophthalmitis

  2018cites this paper
• Incidence and Outcomes of Infectious and Noninfectious Endophthalmitis after Intravitreal Injections for Age-Related Macular Degeneration.

  2018cites this paper
• ATN-161 as an Integrin α5β1 Antagonist Depresses Ocular Neovascularization by Promoting New Vascular Endothelial Cell Apoptosis

  2018cites this paper
• Endophthalmitis Rates after Bilateral Same-Day Intravitreal Anti-Vascular Endothelial Growth Factor Injections.

  2018cites this paper
• Acute Endophthalmitis after Intravitreal Bevacizumab Injections at The Tertiary Centre in Nepal.

  2018cites this paper
• Ref-1/APE1 Inhibition with Novel Small Molecules Blocks Ocular Neovascularization

  2018cites this paper
• Multi-paratopic VEGF decoy receptor have superior anti-tumor effects through anti-EGFRs and targeted anti-angiogenic activities.

  2018cites this paper
• Changing vision: a review of pharmacogenetic studies for treatment response in age-related macular degeneration patients.

  2018cites this paper
• Endophtalmies

  2018cites this paper
• Current treatment strategies and nanocarrier based approaches for the treatment and management of diabetic retinopathy

  2017cites this paper
• Full-thickness macular hole formation following anti-VEGF injections for neovascular age-related macular degeneration

  2017cites this paper
• Severe periocular bleeding induced by bevacizumab in a patient with recurrent glioblastoma multiforme

  2017cites this paper
• Five-year outcomes of pars plana vitrectomy for macular edema associated with branch retinal vein occlusion

  2017cites this paper
• Long-acting protein drugs for the treatment of ocular diseases

  2017cites this paper
• Prevalence and economic burden of extrahepatic manifestations of hepatitis C virus are underestimated but can be improved with therapy

  2017cites this paper
• Gene therapy for the long term treatment of wet AMD.

  2017cites this paper
• Hypoxia‐induced vascular endothelial growth factor secretion by retinal pigment epithelial cells is inhibited by melatonin via decreased accumulation of hypoxia‐inducible factors‐1α protein

  2017cites this paper
• NOVEL CASE OF CLOSTRIDIUM PERFRINGENS ENDOPHTHALMITIS AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTION.

  2017cites this paper
• New molecular targets for the treatment of neovascular age-related macular degeneration

  2017cites this paper
• Infectious and sterile endophthalmitis after intravitreal injections: differential diagnosis, prevention, treatment

  2017cites this paper
• High‐density lipoprotein mutant eye drops for the treatment of posterior eye diseases

  2017cites this paper
• Current advances in the treatment of neovascular age-related macular degeneration

  2017cites this paper
• Therapeutic effects of a novel siRNA-based anti-VEGF (siVEGF) nanoball for the treatment of choroidal neovascularization.

  2017cites this paper
• EXPERIMENTAL VISUALIZATION AND QUANTIFICATION OF VITREOUS CONTAMINATION FOLLOWING INTRAVITREAL INJECTIONS

  2016cites this paper
• Selected Antimicrobial Activity of Topical Ophthalmic Anesthetics

  2016cites this paper
• Rate of intraoperative complications during cataract surgery following intravitreal injections

  2016cites this paper
• Микозы в оториноларингологии: диагностика, профилактика, лечение

  2016cites this paper
• Effect of intraocular pressure (IOP) and choroidal circulation on controlled episcleral drug delivery to retina/vitreous.

  2016cites this paper
• Nurse specialists for the administration of anti-vascular endothelial growth factor intravitreal injections.

  2016cites this paper
• New Developments in Vision Research Selected Antimicrobial Activity of Topical Ophthalmic Anesthetics

  2016cites this paper
• Longitudinal Changes in Retinal Nerve Fiber Layer Thickness after Intravitreal Anti-vascular Endothelial Growth Factor Therapy

  2016cites this paper
• Retro-Mode Scanning Laser Ophthalmoscopy Planning for Navigated Macular Laser Photocoagulation in Macular Edema

  2016cites this paper
• Effect of Prior Anti-VEGF Injections on the Risk of Retained Lens Fragments and Endophthalmitis after Cataract Surgery in the Elderly.

  2016cites this paper
• Characterization of silicone pressure-sensitive adhesive episcleral implant for drug delivery

  2016cites this paper